CStone Pharmaceuticals (HKG:2616)
Hong Kong · Delayed Price · Currency is HKD 7.71
-0.10 (-1.28%)
May 28, 2026, 10:00 AM HKT
CStone Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, CStone Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $14.39. The average 1-year stock price forecast is 86.64% higher than the current stock price, while the lowest is $9.61 (+24.64%) and the highest is $20.35 (+163.94%).
Price Target: $14.39 (+86.64%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 31, 2026.
Analyst Ratings
The average analyst rating for CStone Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Goldman Sachs No rating | Goldman Sachs | Buy Maintains $8.26 → $9.44 | Buy | Maintains | $8.26 → $9.44 | +22.44% | Mar 31, 2026 |
Unknown Analyst Guoyuan Securities (HK) No rating | Guoyuan Securities (HK) | Buy Maintains $10.30 | Buy | Maintains | $10.30 | +33.59% | Mar 3, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.